Structured evidence table for Hyaluronic Joint Health Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Hyaluronic Joint Health Randomized Trial | 25 37 13 5 Hip OA is a major cause of pain, leading to significant mobility limitations, reduced physical capacity and severe impact on the patient's quality of life. | 2 | de Sire Alessandro (2026) | Combined ultrasound‐guided hyaluronic acid injections, high‐power laser therapy and physiotherapy improve hip function in osteoarthritis: A randomized controlled trial |
| Hyaluronic Joint Health Randomized Trial | However, the literature offers few studies, and those available present conflicting results regarding postural changes associated with hip joint damage []. | 2 | de Sire Alessandro (2026) | Combined ultrasound‐guided hyaluronic acid injections, high‐power laser therapy and physiotherapy improve hip function in osteoarthritis: A randomized controlled trial |
| Hyaluronic Joint Health Randomized Trial | Patients with BMI > 30 were excluded to avoid confounding factors related to excessive mechanical load and reduced rehabilitation adherence; suspension of anti‐inflammatory drugs (NSAIDs), opioids, corticosteroids, muscle relaxants or any other therapy that could interfere with the study assessments. | 2 | de Sire Alessandro (2026) | Combined ultrasound‐guided hyaluronic acid injections, high‐power laser therapy and physiotherapy improve hip function in osteoarthritis: A randomized controlled trial |
| Hyaluronic Joint Health Randomized Trial | 28 13 41 The hip joint is one of the primary joints commonly affected by degenerative osteoarthritis (OA) []. | 2 | de Sire Alessandro (2026) | Combined ultrasound‐guided hyaluronic acid injections, high‐power laser therapy and physiotherapy improve hip function in osteoarthritis: A randomized controlled trial |
| Hyaluronic Joint Health Randomized Trial | Corrigendum: Rheological properties and clinical efficacy of a chemically modified hyaluronic acid for joint health enhancement | 4 | Corrigendum: Rheological properties and clinical efficacy of a chemically modified hyaluronic acid for joint health enhancement (2026) | Corrigendum: Rheological properties and clinical efficacy of a chemically modified hyaluronic acid for joint health enhancement |
Source documents